*Department of Pathology, University of Medicine and Pharmacy of Targu Mures, Targu Mures
§Regional Institute of Oncology, Iasi, Romania
†Vancouver General Hospital, Vancouver, BC, Canada
∥Ospedale Sacro Cuore Don Calabria, Negrar, Italy
¶Department of Pathology, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel
#Jikei University School of Medicine, Tokyo, Japan
**Hospital de Oncología Mexico City, Mexico City, Mexico
††Massachusetts General Hospital, Boston, MA
‡Memorial Sloan Kettering Cancer Center, New York, NY
Conflicts of Interest and Source of Funding: This study was funded in part through the NIH/NCI Support Grant P30 CA008748 (R.A.S., K.J.P., and M.C.P.). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Robert A. Soslow, MD, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065 (e-mail: [email protected]).